Huntington National Bank trimmed its holdings in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 5.3% in the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 47,536 shares of the pharmacy operator’s stock after selling 2,634 shares during the quarter. Huntington National Bank’s holdings in Walgreens Boots Alliance were worth $2,015,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors have also made changes to their positions in WBA. Private Ocean LLC bought a new stake in Walgreens Boots Alliance during the first quarter valued at approximately $25,000. Balentine LLC purchased a new position in Walgreens Boots Alliance during the first quarter valued at approximately $29,000. Pearl River Capital LLC purchased a new position in Walgreens Boots Alliance during the first quarter valued at approximately $35,000. Campbell Wealth Management purchased a new position in Walgreens Boots Alliance during the second quarter valued at approximately $35,000. Finally, Perennial Advisors LLC purchased a new position in Walgreens Boots Alliance during the first quarter valued at approximately $36,000. Institutional investors own 57.12% of the company’s stock.
Walgreens Boots Alliance stock opened at $40.71 on Friday. The company has a market cap of $35.28 billion, a price-to-earnings ratio of 49.65, a PEG ratio of 1.74 and a beta of 0.55. The firm’s fifty day moving average is $41.39 and its 200 day moving average is $45.26. The company has a quick ratio of 0.33, a current ratio of 0.69 and a debt-to-equity ratio of 0.57. Walgreens Boots Alliance Inc has a 52-week low of $36.65 and a 52-week high of $64.50.
Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Thursday, July 9th. The pharmacy operator reported $0.83 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.10 by ($0.27). The business had revenue of $34.63 billion for the quarter, compared to analysts’ expectations of $34.32 billion. Walgreens Boots Alliance had a net margin of 0.55% and a return on equity of 19.43%. Walgreens Boots Alliance’s revenue for the quarter was up .1% compared to the same quarter last year. During the same period in the previous year, the company earned $1.47 EPS. On average, equities research analysts anticipate that Walgreens Boots Alliance Inc will post 4.68 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, September 11th. Investors of record on Wednesday, August 19th will be paid a dividend of $0.4675 per share. This is an increase from Walgreens Boots Alliance’s previous quarterly dividend of $0.46. The ex-dividend date is Tuesday, August 18th. This represents a $1.87 dividend on an annualized basis and a yield of 4.59%. Walgreens Boots Alliance’s dividend payout ratio is presently 30.55%.
Several equities analysts have weighed in on the stock. Royal Bank of Canada lowered their price target on shares of Walgreens Boots Alliance from $48.00 to $45.00 and set a “sector perform” rating on the stock in a report on Friday, July 10th. Deutsche Bank lowered their price target on shares of Walgreens Boots Alliance from $43.00 to $38.00 and set a “hold” rating on the stock in a report on Friday, July 10th. Barclays lowered their price target on shares of Walgreens Boots Alliance from $50.00 to $45.00 and set an “equal weight” rating on the stock in a report on Friday, July 10th. ValuEngine downgraded shares of Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a report on Wednesday, May 27th. Finally, Mizuho lowered their target price on shares of Walgreens Boots Alliance from $48.00 to $43.00 and set a “neutral” rating on the stock in a report on Tuesday, July 21st. Four research analysts have rated the stock with a sell rating and fourteen have assigned a hold rating to the company. The stock currently has an average rating of “Hold” and a consensus price target of $46.00.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Recommended Story: Exchange-Traded Funds (ETFs)
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.